You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dongre A, Weinberg R, Rashidian M, et al
232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0232